Literature DB >> 9810618

Antigen heterogeneity among Mycoplasma mycoides subsp. mycoides SC isolates: discrimination of major surface proteins.

R Gonçalves1, J Regalla, J Nicolet, J Frey, R Nicholas, J Bashiruddin, P de Santis, A P Gonçalves.   

Abstract

The protein and antigen profiles of 60 isolates, strains and the type strain PG1 of Mycoplasma mycoides subsp. mycoides s.c. were compared by sodium dodecyl sulphate polyacrylamide gel electrophoresis and immunoblot analysis. Analysis using contagious bovine pleuropneumonia antisera and hyperimmune rabbit sera against several representative strains revealed some differences in protein profiles and variability in antigens among strains from different geographic regions. The most common antigenic bands had the molecular masses of 110, 95, 80, 69, 62, 60, 48, 44, 39 and 38 kDa. There were differences among European strains, where a larger group coming from Italy lacked the p98 antigen, thus, with one exception, distinguishing the Italian strains from Portuguese, French and Spanish strains. African, Australian and PG1 strains showed heterogenic profiles, with quantitative differences and in a few strains some antigenic bands were absent. The group constituting African, Australian and PG1 strains was characterised by the presence of 71.5/70 kDa antigens, which were not detected in European strains. Mycoplasma mycoides subsp. mycoides s.c. membrane proteins were characterised by Triton X-114 partitioning and p110, p98, p95, p62/60 and p48 were identified as immunogenic antigens. The simultaneous presence of these five antigens was common to all the sera examined and, therefore, indicates the diagnostic potential of immunoblotting. Most immunodominant antigens are surface-exposed proteins as determined by the trypsin treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810618     DOI: 10.1016/s0378-1135(98)00214-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  One test microbial diagnostic microarray for identification of Mycoplasma mycoides subsp. mycoides and other Mycoplasma species.

Authors:  A Tonelli; F Sacchini; I Krasteva; K Zilli; M Scacchia; C Beaurepaire; A Nantel; A Pini
Journal:  Mol Biotechnol       Date:  2012-11       Impact factor: 2.695

2.  Protein and antigenic variability among Mycoplasma hyopneumoniae strains by SDS-PAGE and immunoblot.

Authors:  P Assunção; C De la Fe; A S Ramírez; O González Llamazares; J B Poveda
Journal:  Vet Res Commun       Date:  2005-10       Impact factor: 2.459

3.  Mycoplasma agassizii strain variation and distinct host antibody responses explain differences between enzyme-linked immunosorbent assays and Western blot assays.

Authors:  Lori D Wendland; Paul A Klein; Elliott R Jacobson; Mary B Brown
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

4.  Comparative assessment of two commonly used commercial ELISA tests for the serological diagnosis of contagious agalactia of small ruminants caused by Mycoplasma agalactiae.

Authors:  François Poumarat; Dominique Le Grand; Patrice Gaurivaud; Emilie Gay; Myriam Chazel; Yvette Game; Dominique Bergonier
Journal:  BMC Vet Res       Date:  2012-07-09       Impact factor: 2.741

5.  Vaccination of cattle with the N terminus of LppQ of Mycoplasma mycoides subsp. mycoides results in type III immune complex disease upon experimental infection.

Authors:  Musa Mulongo; Joachim Frey; Ken Smith; Christian Schnier; Hezron Wesonga; Jan Naessens; Declan McKeever
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

6.  Identification of genes coding for B cell antigens of Mycoplasma mycoides subsp. mycoides Small Colony (MmmSC) by using phage display.

Authors:  Dubravka R Miltiadou; Arshad Mather; Edy M Vilei; Dion H Du Plessis
Journal:  BMC Microbiol       Date:  2009-10-09       Impact factor: 3.605

7.  Cattle immunized against the pathogenic L-α-glycerol-3-phosphate oxidase of Mycoplasma mycoides subs. mycoides fail to generate neutralizing antibodies and succumb to disease on challenge.

Authors:  Musa M Mulongo; Joachim Frey; Ken Smith; Christian Schnier; Hezron Wesonga; Jan Naessens; Declan McKeever
Journal:  Vaccine       Date:  2013-09-11       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.